Signaturefd, LLC Mirati Therapeutics, Inc. Transaction History

Signaturefd, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$41.99 - $62.38 $18,643 - $27,696	444 Added 76.95%	1,021 $59,000
Q3 2023 Nov 03, 2023	BUY	$27.8 - $45.35 $7,700 - $12,561	277 Added 92.33%	577 $25,000
Q2 2023 Aug 01, 2023	BUY	$36.13 - $49.49 $2,312 - $3,167	64 Added 27.12%	300 $10,000
Q1 2023 Apr 28, 2023	SELL	$36.54 - $54.26 $11,290 - $16,766	-309 Reduced 56.7%	236 $8,000
Q4 2022 Jan 27, 2023	SELL	$41.27 - $98.62 $33,181 - $79,290	-804 Reduced 59.6%	545 $24,000
Q3 2022 Nov 08, 2022	BUY	$59.5 - $86.7 $2,142 - $3,121	36 Added 2.74%	1,349 $94,000
Q2 2022 Aug 10, 2022	BUY	$39.16 - $88.71 $38,181 - $86,492	975 Added 288.46%	1,313 $88,000
Q1 2022 May 02, 2022	BUY	$75.82 - $150.97 $12,965 - $25,815	171 Added 102.4%	338 $28,000
Q4 2021 Jan 25, 2022	BUY	$132.01 - $190.29 $18,481 - $26,640	140 Added 518.52%	167 $24,000
Q3 2021 Oct 28, 2021	BUY	$132.13 - $177.45 $396 - $532	3 Added 12.5%	27 $5,000
Q2 2021 Jul 26, 2021	BUY	$144.0 - $179.73 $864 - $1,078	6 Added 33.33%	24 $4,000
Q1 2021 Apr 30, 2021	SELL	$158.92 - $221.61 $2,542 - $3,545	-16 Reduced 47.06%	18 $3,000
Q4 2020 Feb 11, 2021	BUY	$162.05 - $240.27 $3,241 - $4,805	20 Added 142.86%	34 $7,000
Q2 2020 Jul 30, 2020	BUY	$72.01 - $120.39 $1,008 - $1,685	14 New	14 $2,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.